NAMCP Home Page

NAMCP Medical Directors Oncology Institute

Oncology Institute

Director: Alan Adler, MD, Senior Medical Director, Independence Blue Cross

The NAMCP Oncology Institute is supported by:
Amgen, Inc, Astellas Pharma US, Inc, Bayer Healthcare, Bristol-Myers Squibb, Celgene Corporation, CVS Caremark, Dendreon, Eisai, Exact Sciences Corporation, Express Scripts, Genentech, Genomic Health, GlaxoSmithKline, Lilly Oncology, Novartis Oncology, Onyx Pharmaceuticals, Pfizer Oncology Managed Markets, Seattle Genetics and Teva Pharmaceuticals.
  Click Here For the NAMCP Medical Directors Guide: Oncology  
Want to be involved?
Click Here
Oncology Disease State
CME/CEU Activities
Click here to learn more about the current state of Oncology

Resources for Medical Directors from Purchasers (Employers), Plans and Provider Systems
Click Here

Medical Directors Oncology
Resource Centers

Resources for Patients
Click Here

Institute’s Mission


The purpose of the Medical Directors Oncology Institute is to provide increased and on-going information and resources to Medical Directors from Purchasers, Health Plans and Provider Systems about Cancer. The Institute is led by an Executive Leadership Council of Medical Directors from purchasers, health plans and provider systems.

The NAMCP Medical Directors Oncology Institute is becoming very active in the world of oncology. We have had conversations with COA, NCCN and ASCO on working with medical directors to improve communications and issues between oncologists, hospitals and medical directors.

What have we accomplished?




Want to be involved in the Oncology Institute?

Complete this form and let us know of your interest.




Help us cut down spam.

Type the number 411 into
the following box (Required)